RecruitingNCT07481526

A Prospecitve Multicenter, Observational Registry Study

A Multicenter Real-World Registry of Characteristics, Treatment Strategies, and Clinical Outcomes in Chinese Adults With Chronic Kidney Disease


Sponsor

AstraZeneca

Enrollment

3,000 participants

Start Date

Feb 27, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective, multicenter, observational registry study designed to collect data to deepen the understanding of CKD therapeutics, changes in clinical practice, cardiorenal risk outcomes and differences in treatment approaches in Chinese CKD patients.


Eligibility

Plain Language Summary

Simplified for easier understanding

This is an observational registry study that tracks patients with chronic kidney disease (CKD) — a condition where the kidneys gradually lose their ability to filter waste from the blood. The aim is to collect real-world data on how CKD progresses and how it is managed over time, which can help doctors improve care in the future. **You may be eligible if...** - You are 18 years or older - You have a confirmed diagnosis of chronic kidney disease, meaning your kidney function has been reduced for at least 3 months - You are willing to provide informed written consent **You may NOT be eligible if...** - You have a life-threatening illness with a life expectancy under 2 years - You have had a serious heart event (heart attack, stroke) in the past 3 months - You are pregnant or breastfeeding - You are currently participating in another interventional clinical trial - Your kidney disease has progressed to end-stage kidney failure requiring dialysis, or your condition is classified as acute (sudden onset) kidney injury Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Zhongshan Hospital Affilicated with Fudan University

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07481526


Related Trials